甲状腺结节(Thyroid nodules, TN)是甲状腺最常见的一种临床疾病,一般由甲状腺细胞在颈部异常生长而引起,临床常以甲状腺局部出现肿块、咽喉部吞咽时有异物感、结节逐渐增大时容易导致压迫症状为主要特征。甲状腺结节的西医发病机制相...甲状腺结节(Thyroid nodules, TN)是甲状腺最常见的一种临床疾病,一般由甲状腺细胞在颈部异常生长而引起,临床常以甲状腺局部出现肿块、咽喉部吞咽时有异物感、结节逐渐增大时容易导致压迫症状为主要特征。甲状腺结节的西医发病机制相对复杂,涉及多个方面。中医学认为甲状腺结节的发生与人体气血失调、脏腑功能失和密切相关。在辨证论治方面,中医学强调个体化治疗,根据患者的具体病情和体质特点进行辨证分析。因此本文主要通过分析其发病机制与危险因素,研究病因病机,探讨辨证论治以及了解临床常见的中医治疗方法,从而对之前医家治疗本病的临床经验进行总结,以求进一步完善甲状腺结节的中医药治疗理论体系。Thyroid nodules (Thyroid nodules, TN) is the most common clinical disease of thyroid, which is usually caused by abnormal growth of thyroid cells in the neck. Clinically, the local thyroid mass, foreign body sensation in the throat, and the nodules gradually increase. The western medicine pathogenesis of thyroid nodules is relatively complex and involves many aspects. Traditional Chinese medicine believes that the occurrence of thyroid nodules is closely related to the imbalance of qi and blood and the loss of viscera function. In terms of syndrome differentiation and treatment, traditional Chinese medicine emphasizes individualized treatment, and conducts syndrome differentiation analysis according to the patients’ specific conditions and physical characteristics. Therefore, this paper mainly analyzes the pathogenesis and risk factors, studies the causes and mechanisms, discusses the syndrome differentiation treatment and understands the common clinical TCM treatment methods, so as to summarize the previous clinical experience of the treatment of this disease, in order to further improve the theoretical system of TCM treatment of thyroid nodules.展开更多
糖尿病肾病是糖尿病患者常见的并发症之一,疾病预后较差,是糖尿病患者的主要死因之一,糖尿病肾病西医治疗方法较为单一。近年来中医在防治糖尿病肾病的疾病进展、保护肾功能、延缓病情发展方面取得了较为满意的疗效。Diabetic nephropat...糖尿病肾病是糖尿病患者常见的并发症之一,疾病预后较差,是糖尿病患者的主要死因之一,糖尿病肾病西医治疗方法较为单一。近年来中医在防治糖尿病肾病的疾病进展、保护肾功能、延缓病情发展方面取得了较为满意的疗效。Diabetic nephropathy is one of the common complications of diabetic patients, the disease prognosis is poor, is one of the main causes of death of diabetic patients, diabetic nephropathy western medicine treatment method is relatively single. In recent years, Chinese medicine in the prevention and treatment of diabetic nephropathy disease progression, protection of renal function, delaying the development of the disease has achieved more satisfactory results.展开更多
桥本甲状腺炎合并甲状腺功能减退症是临床常见的内分泌疾病,近年来其发病率呈不断上升的趋势。西医治疗主要采取甲状腺激素替代疗法作为核心手段,虽有一定疗效,但长期使用需注意其潜在副作用和个体化剂量的调整。相比之下,中药复方通过...桥本甲状腺炎合并甲状腺功能减退症是临床常见的内分泌疾病,近年来其发病率呈不断上升的趋势。西医治疗主要采取甲状腺激素替代疗法作为核心手段,虽有一定疗效,但长期使用需注意其潜在副作用和个体化剂量的调整。相比之下,中药复方通过从肝脾肾三脏入手,辨证施治,展现出在缓解症状、调节免疫、延缓病情进展及提高患者生活质量方面的显著优势。本文汇总并分析了相关文献,综述了从肝、脾、肾三脏出发治疗桥本甲减的理论认知与诊疗发展,旨在为该病的临床诊断和治疗提供新的思考路径。Hashimoto’s thyroiditis with hypothyroidism is a common clinical endocrine disease, and its incidence has been increasing in recent years. Western medicine mainly adopts Thyroid hormone replacement therapy as its core method. Although it has some curative effect, it needs to pay attention to its potential side effects and individual dose adjustment for long-term use. In contrast, Chinese herbal medicine formula has shown significant advantages in relieving symptoms, regulating immunity, delaying disease progression and improving patients’ quality of life by treating liver, spleen and kidney according to syndrome differentiation. This article summarized and analyzed the related literature, and reviewed the development of the theory and treatment of hypothyroidism Hashimoto from the liver, spleen and kidney, in order to provide a new way of thinking for the clinical diagnosis and treatment of hypothyroidism.展开更多
目的:探讨桥本氏甲状腺炎(HT)是否会导致肥胖患者的卵巢储备功能下降。方法:选取黑龙江中医药大学附属第一医院内分泌科门诊系统中2017年7月~2018年10月共计189例,符合《中国成人肥胖症防治专家共识》诊断标准的肥胖患者作为研究对象进...目的:探讨桥本氏甲状腺炎(HT)是否会导致肥胖患者的卵巢储备功能下降。方法:选取黑龙江中医药大学附属第一医院内分泌科门诊系统中2017年7月~2018年10月共计189例,符合《中国成人肥胖症防治专家共识》诊断标准的肥胖患者作为研究对象进行回顾性研究;分析肥胖 + HT患者与肥胖 + 非HT患者之间一般临床特征、糖脂代谢指标、甲状腺功能指标、抗苗勒管激素(AMH)的差异,以及AMH与甲状腺功能指标相关性。结果:肥胖 + HT组与肥胖 + 非HT组间HDL、脂蛋白a、TSH、TG-AB、APO-AB,差异具有显著性(P Objective: To investigate whether Hashimoto’s thyroiditis (HT) can lead to the decline of ovarian reserve function in obese patients. Methods: A retrospective study was conducted on 189 obese patients who met the diagnostic criteria of China Adult Obesity Prevention and Treatment Expert Consensus from July 2017 to October 2018 in the outpatient system of endocrinology department of the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine. To analyze the differences between obese + HT patients and obese + non-HT patients in general clinical features, glucose and lipid metabolism indexes, thyroid function indexes and anti-Mullerian hormone (AMH), and the correlation between AMH and thyroid function indexes. Results: There were significant differences in HDL, lipoprotein A, TSH, TG-AB and APO-AB between obese + HT group and obese + non-HT group (P < 0.05). Results: Whether HT can reduce the ability of ovarian reserve in obese patients still needs further study and exploration. HT may aggravate the inhibition of follicular development in obese patients and increase the risk of menstrual cycle disorder in obese patients.展开更多
围绝经期综合征是临床常见疾病之一,自然绝经或人工绝经都可引发此病。此病症状复杂,病程长短不一,西医多通过激素补充治疗,见效快,但是禁忌证、不良反应相对较多。祖国医学中对于此病并无明确记载,现多将其归为“绝经前后诸证”的范畴...围绝经期综合征是临床常见疾病之一,自然绝经或人工绝经都可引发此病。此病症状复杂,病程长短不一,西医多通过激素补充治疗,见效快,但是禁忌证、不良反应相对较多。祖国医学中对于此病并无明确记载,现多将其归为“绝经前后诸证”的范畴。现代中医继承前人从肾论治此病的经验,发展到现在从肝肾论治此病,本文对近5年来有关中医药从肝肾论治围绝经期综合征的文献进行归纳、整理和总结,以期为今后中医药治疗在防治围绝经期综合征方面提供更多的借鉴与参考。Perimenopausal syndrome is one of the common clinical diseases, natural menopause or artificial menopause can cause this disease. The symptoms of this disease are complex, and the length of the disease is different. Western medicine mostly treats it with hormone supplement, which has a quick effect, but there are many contraindications, and adverse reactions are relatively more. There is no clear record of this disease in Chinese medicine, and it is often classified as the category of “before and after menopausal symptoms”. Modern traditional Chinese medicine predecessors inherit the experience of treating this disease from the kidney theory and develop the treatment of this disease from the liver and kidney theory. This article summarizes, organizes, and concludes the literature on the treatment of perimenopausal syndrome in traditional Chinese medicine from the liver and kidney theory in the past five years, in order to provide more reference for the future treatment of traditional Chinese medicine in the prevention and treatment of perimenopausal syndrome.展开更多
文摘甲状腺结节(Thyroid nodules, TN)是甲状腺最常见的一种临床疾病,一般由甲状腺细胞在颈部异常生长而引起,临床常以甲状腺局部出现肿块、咽喉部吞咽时有异物感、结节逐渐增大时容易导致压迫症状为主要特征。甲状腺结节的西医发病机制相对复杂,涉及多个方面。中医学认为甲状腺结节的发生与人体气血失调、脏腑功能失和密切相关。在辨证论治方面,中医学强调个体化治疗,根据患者的具体病情和体质特点进行辨证分析。因此本文主要通过分析其发病机制与危险因素,研究病因病机,探讨辨证论治以及了解临床常见的中医治疗方法,从而对之前医家治疗本病的临床经验进行总结,以求进一步完善甲状腺结节的中医药治疗理论体系。Thyroid nodules (Thyroid nodules, TN) is the most common clinical disease of thyroid, which is usually caused by abnormal growth of thyroid cells in the neck. Clinically, the local thyroid mass, foreign body sensation in the throat, and the nodules gradually increase. The western medicine pathogenesis of thyroid nodules is relatively complex and involves many aspects. Traditional Chinese medicine believes that the occurrence of thyroid nodules is closely related to the imbalance of qi and blood and the loss of viscera function. In terms of syndrome differentiation and treatment, traditional Chinese medicine emphasizes individualized treatment, and conducts syndrome differentiation analysis according to the patients’ specific conditions and physical characteristics. Therefore, this paper mainly analyzes the pathogenesis and risk factors, studies the causes and mechanisms, discusses the syndrome differentiation treatment and understands the common clinical TCM treatment methods, so as to summarize the previous clinical experience of the treatment of this disease, in order to further improve the theoretical system of TCM treatment of thyroid nodules.
文摘糖尿病肾病是糖尿病患者常见的并发症之一,疾病预后较差,是糖尿病患者的主要死因之一,糖尿病肾病西医治疗方法较为单一。近年来中医在防治糖尿病肾病的疾病进展、保护肾功能、延缓病情发展方面取得了较为满意的疗效。Diabetic nephropathy is one of the common complications of diabetic patients, the disease prognosis is poor, is one of the main causes of death of diabetic patients, diabetic nephropathy western medicine treatment method is relatively single. In recent years, Chinese medicine in the prevention and treatment of diabetic nephropathy disease progression, protection of renal function, delaying the development of the disease has achieved more satisfactory results.
文摘桥本甲状腺炎合并甲状腺功能减退症是临床常见的内分泌疾病,近年来其发病率呈不断上升的趋势。西医治疗主要采取甲状腺激素替代疗法作为核心手段,虽有一定疗效,但长期使用需注意其潜在副作用和个体化剂量的调整。相比之下,中药复方通过从肝脾肾三脏入手,辨证施治,展现出在缓解症状、调节免疫、延缓病情进展及提高患者生活质量方面的显著优势。本文汇总并分析了相关文献,综述了从肝、脾、肾三脏出发治疗桥本甲减的理论认知与诊疗发展,旨在为该病的临床诊断和治疗提供新的思考路径。Hashimoto’s thyroiditis with hypothyroidism is a common clinical endocrine disease, and its incidence has been increasing in recent years. Western medicine mainly adopts Thyroid hormone replacement therapy as its core method. Although it has some curative effect, it needs to pay attention to its potential side effects and individual dose adjustment for long-term use. In contrast, Chinese herbal medicine formula has shown significant advantages in relieving symptoms, regulating immunity, delaying disease progression and improving patients’ quality of life by treating liver, spleen and kidney according to syndrome differentiation. This article summarized and analyzed the related literature, and reviewed the development of the theory and treatment of hypothyroidism Hashimoto from the liver, spleen and kidney, in order to provide a new way of thinking for the clinical diagnosis and treatment of hypothyroidism.
文摘目的:探讨桥本氏甲状腺炎(HT)是否会导致肥胖患者的卵巢储备功能下降。方法:选取黑龙江中医药大学附属第一医院内分泌科门诊系统中2017年7月~2018年10月共计189例,符合《中国成人肥胖症防治专家共识》诊断标准的肥胖患者作为研究对象进行回顾性研究;分析肥胖 + HT患者与肥胖 + 非HT患者之间一般临床特征、糖脂代谢指标、甲状腺功能指标、抗苗勒管激素(AMH)的差异,以及AMH与甲状腺功能指标相关性。结果:肥胖 + HT组与肥胖 + 非HT组间HDL、脂蛋白a、TSH、TG-AB、APO-AB,差异具有显著性(P Objective: To investigate whether Hashimoto’s thyroiditis (HT) can lead to the decline of ovarian reserve function in obese patients. Methods: A retrospective study was conducted on 189 obese patients who met the diagnostic criteria of China Adult Obesity Prevention and Treatment Expert Consensus from July 2017 to October 2018 in the outpatient system of endocrinology department of the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine. To analyze the differences between obese + HT patients and obese + non-HT patients in general clinical features, glucose and lipid metabolism indexes, thyroid function indexes and anti-Mullerian hormone (AMH), and the correlation between AMH and thyroid function indexes. Results: There were significant differences in HDL, lipoprotein A, TSH, TG-AB and APO-AB between obese + HT group and obese + non-HT group (P < 0.05). Results: Whether HT can reduce the ability of ovarian reserve in obese patients still needs further study and exploration. HT may aggravate the inhibition of follicular development in obese patients and increase the risk of menstrual cycle disorder in obese patients.
文摘围绝经期综合征是临床常见疾病之一,自然绝经或人工绝经都可引发此病。此病症状复杂,病程长短不一,西医多通过激素补充治疗,见效快,但是禁忌证、不良反应相对较多。祖国医学中对于此病并无明确记载,现多将其归为“绝经前后诸证”的范畴。现代中医继承前人从肾论治此病的经验,发展到现在从肝肾论治此病,本文对近5年来有关中医药从肝肾论治围绝经期综合征的文献进行归纳、整理和总结,以期为今后中医药治疗在防治围绝经期综合征方面提供更多的借鉴与参考。Perimenopausal syndrome is one of the common clinical diseases, natural menopause or artificial menopause can cause this disease. The symptoms of this disease are complex, and the length of the disease is different. Western medicine mostly treats it with hormone supplement, which has a quick effect, but there are many contraindications, and adverse reactions are relatively more. There is no clear record of this disease in Chinese medicine, and it is often classified as the category of “before and after menopausal symptoms”. Modern traditional Chinese medicine predecessors inherit the experience of treating this disease from the kidney theory and develop the treatment of this disease from the liver and kidney theory. This article summarizes, organizes, and concludes the literature on the treatment of perimenopausal syndrome in traditional Chinese medicine from the liver and kidney theory in the past five years, in order to provide more reference for the future treatment of traditional Chinese medicine in the prevention and treatment of perimenopausal syndrome.
